Cardiac troponin T and familial hypertrophic cardiomyopathy: An energetic affair

Journal of Clinical Investigation

Volumn 112, Issue 5, 2003, Pages 652-654

  Schwartz, Ketty ^a   Mercadier, Jean Jacques ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T;

CARDIOMYOPATHY; ENERGY METABOLISM; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HEART CONTRACTION; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; MISSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; GENETICS; HEART MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; METABOLISM; MUTATION; NOTE;

CARDIOMYOPATHY, HYPERTROPHIC; ENERGY METABOLISM; HUMANS; MUTATION; MYOCARDIUM; TROPONIN T;

EID: 0141835059     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200319632     Document Type: Review

References (24)

1. Maron, B.J., and Ferrans, V.J. 1978. Ultrastructural features of hypertrophied human ventricular myocardium. Prog. Cardiovasc. Dis. 21:207-238.
2. Komajda, M., and Grosgogeat, Y. 1990. Myocardiopathies. In Recherches en hypertrophie et insuffisances cardiaques. B. Swynghedauw, editor. INSERM/John Libbey Eurotext Ltd. Montrouge, France. 505-522.
3. Schwartz, K., Carrier, L., Guicheney, P., and Komajda, M. 1995. Molecular basis of familial cardiomyopathies. Circulation. 91:532-540.
4. Roberts, R., and Sigwart, U. 2001. New concepts in hypertrophic cardiomyopathies, part I. Circulation. 104:2113-2116.
5. Roberts, R., and Sigwart, U. 2001. New concepts in hypertrophic cardiomyopathies, part II. Circulation. 104:2249-2252.
6. Maron, B.J., et al. 1987. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 10:733-742.
7. McKenna, W., et al. 1981. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am. J. Cardiol. 47:532-538.
8. Richard, P., et al. 2003. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations and implications for molecular diagnosis strategy. Circulation. 107:2227-2232.
9. Redwood, C.S., Moolman-Smook, J.C., and Watkins, H. 1999. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc. Res. 44:20-36.
10. Watkins, H., et al. 1995. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332:1058-1064.
11. Javadpour, M.M., Tardiff, J.C., Pinz, I., and Ingwall, J.S. 2003. Decreased energetics in murine hearts bearing the RD2Q mutation in cardiac troponin T. J. Clin. Invest. 112:768-775. doi:10.1172/JCI200315967.
12. Palm, T., Graboski, S., Hitchcock-DeGregori, S.E., and Greenfeld, N.J. 2001. Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region. Biophys. J. 81:2827-2837.
13. Tobacman, L.S., et al. 2002. The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity. J. Biol. Chem. 277:27636-27642.
14. Greenfield, N.J., Palm, T., and Hitchcock-DeGregori, S.E. 2002. Structure and interactions of the carboxyl terminus of striated muscle α-tropomyosin: it is important to be flexible. Biophys. J. 83:2754-2766.
15. Gomes, A.V., Guzman, G., Zhao, J., and Potter, J.D. 2002. Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development. J. Biol. Chem. 277:35341-35349.
16. Maytum, R., Geeves, M.A., and Lehrer, S. 2002. A modulatory role for the troponin T tail domain in thin filament regulation. J. Biol. Chem. 277:29774-29780.
17. Hinkle, A., and Tobacman, L.S. 2003. Folding and funcrion of the troponin tail domain. J. Biol. Chem. 278:506-513.
18. Tardiff, J.C., et al. 1998. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J. Clin. Invest. 101:2800-2811.
19. Lim, D.S., et al. 2000. Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q92, responsible for human hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 32:365-374.
20. Sweeney, H.L., Feng, H.S., Yang, Z., and Watkins, H. 1998. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc. Natl. Acad. Sci. U. S. A. 95:14406-14410.
21. Rust, E.M., Albayya, F.P., and Metzger, J.M. 1999. Identification of a contractile deficit in adult cardiac-myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins. J. Clin. Invest. 103:1459-1467.
22. 2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am. J. Physiol. 275:C200-C20wil7.
23. Robinson, P., et al. 2002. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J. Biol. Chem. 277:40710-40716.
24. Tian, R., and Ingwall, J.S. 1996. Energetic basis for reduced contractile reserve in isolated rat hearts. Am. J. Physiol. 270:1207-1216.